PLYX Polaryx Therapeutics, Inc. Common Stock

XNAS
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

PLYX — —
Key stats
About
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834) · industry map
Exchange
XNAS
Market Cap
$0.1B
List Date
2026-02-02
CIK
0002075320
Next Earnings
2026-11-12
EPS Forecast
($0.06)
Headquarters
Paramus, NJ
Homepage
https://www.polaryx.com

Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small-molecule drug candidates designed to address core pathological mechanisms common to LSDs. The Company has one reportable segment: lysosomal storage disorders. The lysosomal sto…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'26Avg
Jan----
Feb-91.29%-91.29%
Mar162.50%162.50%
Apr-30.92%-30.92%
May-32.99%-32.99%
Jun-5.00%-5.00%
Jul-11.66%-11.66%
Aug-8.22%-8.22%
Sep4.55%4.55%
Oct-13.37%-13.37%
Nov2.86%*2.86%
Dec----
Total-92.41%-92.41%
* Only 1 year(s) of data available.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $1.89
SMA 50: $1.99
SMA 200: —
Current: $1.80
EMA 12: $1.83
EMA 26: $1.91
MACD: -0.0712 | Signal: -0.0105
BEARISH
ADX (14): 25.70
TREND
+DI: 11.57
−DI: 20.24

Momentum Oscillators

RSI (14): 39.73
NEUTRAL
Stoch %K: 17.72
Stoch %D: 13.19
Williams %R: -67.67

Volume & Volatility

BB Upper: $2.06
BB Lower: $1.72
NEUTRAL
OBV: 76,724,914
Vol SMA 20: 27,956
Vol ROC: -16.70%
ATR: $0.11
True Range: $0.12
HV 20: 42.7%
HV 30: 38.4%
HV 60: 68.6%

Data Summary

Data Points: 192
Last Updated:
Date Range: 2026-02-02T00:00:00 – 2026-11-04T00:00:00
AI Analysis

LLM Stock Analysis Report: PLYX

Executive Summary

BULLISH/BEARISH: NEUTRAL (Confidence Level: 6)

Key drivers:

  • Neutral technical signals, with some bullish momentum
  • Low volatility and moderate trend strength

Primary risks:

  • Lack of clear trends or catalysts for significant price movement
  • High beta indicating above-average volatility

Investment thesis: PLYX appears to be in a consolidation phase, with no strong catalysts driving the stock price. The recent neutral technical signals suggest a wait-and-see approach, considering the high volatility and moderate trend strength.

Recent news sentiment impact: No recent news available, so no significant impact on sentiment or price movement.

Technical Analysis

Trend Direction: Short-term (1-4 weeks): Consolidation/Neutral; Medium-term (1-3 months): Weak Bullish; Long-term (3-12 months): Neutral

Support/Resistance Levels: Key levels from moving averages and technical patterns:

  • Upper Bollinger Band: $2.49
  • Middle Bollinger Band: $2.19
  • Lower Bollinger Band: $1.88
  • SMA 20: $2.19
  • SMA 50: $2.30

Momentum Signals: RSI interpretation (overbought >70, oversold <30): Neutral at 43.24 (not overbought or oversold) MACD signal (bullish/bearish crossover): Bearish with -0.05 / Signal: -0.00 Bollinger Bands position: Neutral with a squeeze

Volume Analysis: Volume trends and institutional interest signals:

  • Volume SMA 20: 117329.79
  • On-Balance Volume (OBV): 77248223.69
  • Volume Rate of Change: 55.15%

News & Sentiment Analysis

Recent Headlines Summary: No recent news available.

Sentiment Assessment: Neutral sentiment due to lack of significant news or market-moving events.

Catalyst Identification: None identified, but earnings data would provide valuable insight into company performance and future prospects.

Market Narrative: Consolidation phase with no clear direction; market participants waiting for catalysts or new information.

Risk & Volatility Assessment

Beta Interpretation: High risk relative to the market (beta = 1.18).

Volatility Regime: Above-average volatility, but declining trend strength suggests potential for reduced volatility.

Options Market Signals: No options data available.

Downside Protection: Support levels:

  • Lower Bollinger Band: $1.88
  • SMA 20: $2.19

Market Context & Positioning

Sector Performance: Neutral performance relative to the sector/market.

Institutional Activity: Moderate institutional interest, but no clear direction or trend.

Correlation Analysis: Weak positive correlation with the market (R-squared = 0.08).

Relative Valuation: PLYX appears fairly valued within its trading range.

Key Levels & Action Items

Critical Price Levels: Support/resistance to monitor:

  • Upper Bollinger Band: $2.49
  • Middle Bollinger Band: $2.19
  • Lower Bollinger Band: $1.88
  • SMA 20: $2.19
  • SMA 50: $2.30

Breakout/Breakdown Levels: Technical levels that could trigger significant moves:

  • Upper Bollinger Band: $2.49 (bullish)
  • Lower Bollinger Band: $1.88 (bearish)

Time-Sensitive Catalysts: Earnings data would provide valuable insight into company performance and future prospects.

Risk Management: Stop-loss levels and position sizing considerations:

  • Consider a stop-loss order below the Lower Bollinger Band ($1.88)
  • Adjust position size based on risk tolerance and market conditions

Note: This analysis is provided as a template, and actual results may vary based on real-time data and evolving market conditions.

Generated
News
All PLYX news →

PLYX Options Activity & IV Rank

Loading options activity...
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis

Risk Metrics

Beta: 1.3288
Alpha: -231.80%
Correlation: 0.0932
R-Squared: 0.9%
Stock Volatility: 190.2%
Market Volatility: 13.3%

Analysis Details

Benchmark: SPY
Data Points: 191
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
Beta & Alpha Over Time

PLYX Institutional Ownership (13F)

Latest filings — 2026-06-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

12 filers2,192,910 shares$5.83M value
# Filer Shares Value % of Total % of Float Period
1 Vanguard Capital Management LLC 1,657,872 $4.41M 75.60% — 2026-06-30
2 Geode Capital Management, LLC Custodian 170,998 $455.08K 7.80% — 2026-06-30
3 Vanguard Fiduciary Trust Co 105,072 $279.49K 4.79% — 2026-06-30
4 HRT FINANCIAL LP 82,094 $218.00K 3.74% — 2026-06-30
5 State Street Corp 58,104 $154.56K 2.65% — 2026-06-30
6 BlackRock, Inc. Custodian 41,012 $109.09K 1.87% — 2026-06-30
7 Jane Street Group, LLC Custodian 31,441 $83.63K 1.43% — 2026-06-30
8 Northern Trust Corp Custodian 27,987 $74.44K 1.28% — 2026-06-30
9 Allworth Financial LP Custodian 7,727 $20.55K 0.35% — 2026-06-30
10 Vanguard Global Advisers, LLC 6,318 $16.81K 0.29% — 2026-06-30
11 Tower Research Capital LLC (TRC) Custodian 3,002 $7.99K 0.14% — 2026-06-30
12 UBS Group AG Custodian 1,283 $3.41K 0.06% — 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

PLYX Insider Trading (Form 4)

Latest: 2026-05-28
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-05-28 Alex Keun Mo Yang Chief Executive Officer Buy (P) +88,453 $4.07 $360.0K EDGAR
2026-02-20 G. Michael Landis Chief Financial Officer Buy (P) +2,867 $2.79 $8.0K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

PLYX Insider Holdings

2 insiders · @ $1.80
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Alex Keun Mo Yang Chief Executive Officer 24,233,249 $43.62M $360.0K 1 2026-05-28
2 G. Michael Landis Chief Financial Officer 228,225 $410.8K $8.0K 1 2026-02-20
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

PLYX Board & Officers

As of SEC filings through May 28, 2026

Directors 6

Officers 4

  • Alex Keun Mo Yang · Chief Executive Officer · since Jan 29, 2026
  • G. Michael Landis · Chief Financial Officer · since Jan 29, 2026
  • Andrew John O · Chief Investment Officer · since Jan 29, 2026
  • Lisa Bollinger · Chief Medical Officer · since Jan 29, 2026

10% owners 2

  • Alex Keun Mo Yang · since Jan 29, 2026
  • Mstone Partners Healthcare Ltd (entity) · since Jan 29, 2026
Changes in the last 10 years (12)
Jan 29, 2026Mstone Partners Healthcare Ltd became a director
Jan 29, 2026Mstone Partners Healthcare Ltd became a 10% owner
Jan 29, 2026Mitchel Berger became a director
Jan 29, 2026Lisa Bollinger became Chief Medical Officer
Jan 29, 2026III Francis A Braun became a director
Jan 29, 2026G. Michael Landis became a director
Jan 29, 2026G. Michael Landis became Chief Financial Officer
Jan 29, 2026Charles S. Ryan became a director
Jan 29, 2026Andrew John O became Chief Investment Officer
Jan 29, 2026Alex Keun Mo Yang became a director
Jan 29, 2026Alex Keun Mo Yang became a 10% owner
Jan 29, 2026Alex Keun Mo Yang became Chief Executive Officer
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
2 ETFs hold PLYX
2 shown · $3.33M total exposure
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $3.0M — 2026-09-30
2 VXF Vanguard Extended Market ETF Vanguard 0.00% $289,788 — 2026-09-30
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.